Global Mosquito-Borne Disease Has Cure, But Challenges Remain
A promising antiviral drug called mosnodenvir has shown effectiveness in preventing dengue infection, but Johnson & Johnson has abandoned its development, leaving a critical gap in treatment options as dengue spreads globally due to climate change.